Bentham Open announces the launch of new journal, “The Open Biomaterials Science Journal”
Bentham Open is pleased to announce the launch of new subscription-based journal, The Open Biomaterials Science Journal. The first issue ...
Bentham Open is pleased to announce the launch of new subscription-based journal, The Open Biomaterials Science Journal. The first issue ...
Computational tool by USC researchers solves the 'community detection' problem The social network Linkedin will tell a user how he/she ...
Bentham Science is pleased to announce the launch of a new subscription-based journal, Current Chinese Chemistry. The first issue of ...
Bentham Science is pleased to announce the launch of a new subscription-based journal, Current Chinese Medical Science. The first issue ...
Bentham Science is pleased to announce the launch of a new subscription-based journal, Venoms and Toxins. The first issue of ...
National Psoriasis Foundation Awards $2.8 Million in Research Grants and Fellowships Portland, Ore. (July 12, 2019)--The National Psoriasis Foundation, NPF, ...
Prozac®, the trade name for the drug fluoxetine, was introduced to the U.S. market for the treatment of depression in ...
Credit: Laboratory of Membrane Biology and Biophysics at The Rockefeller University In recent decades, treatment options for people with cystic ...
Not only are they effective against Gram-positive and negative multi-resistant bacteria, they also appear not to trigger resistance when used ...
New method synthesizes and evaluates large number of drug leadsCredit: Neochoritis et al. / Science Advances University of Groningen Professor ...
Credit: S. Gerber (EPFL) Theranostics is an emerging field of medicine whose name is a combination of "therapeutics" and "diagnostics". ...
Credit: Image by Caitlin Devor, The University of Tokyo, CC-BY Researchers in Japan have identified multiple promising new drug candidates ...
Where pharma spends, docs prescribe more gabapentin, a potential drug of abuse Pharmaceutical companies' payments to doctors may be influencing ...
Alex Zhavoronkov, Ph.D., Founder and CEO of Insilico Medicine, to present "Machine Learning: From Omics Data, Novel Targets and Biomarker ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.